Strategic Expansion Avalere Health is expanding globally with new strategic offerings and a focus on supporting Japanese biopharma across the product lifecycle. This signals potential opportunities in market access, policy, and regulatory guidance for multinational clients and partnerships in Asia.

Genomics & CGP Recent launches centered on genomic profiling and precision cancer care create demand for advisory, access, and evidence generation services to help health systems embed CGP into routine care, offering a path to collaborate on payer value propositions and patient access initiatives.

Market Accessibility New guides and pathways to improve patient access point to opportunities in real-world evidence, payer strategy, and digital experience solutions to streamline access programs, reimbursement, and patient navigation for therapies with complex entry criteria.

Policy Expertise Senior leadership in policy and public health, plus experience with 340B data analytics, suggests selling points around compliance, policy monitoring, and strategic communications to biopharma clients navigating complex regulatory landscapes.

Digital & Tech Enablement Tech stack emphasis on analytics, cloud, and digital experience platforms indicates scope for selling marketing automation, data-driven commercialization, and patient engagement campaigns powered by integrated technology solutions.